The FDA Peptide Vote: What Everyone Reported, What Nobody Is Talking About, and What Actually Matters Now
By RUOcodes.com Research Team
Published: · Updated: Sep 10, 2026
Who voted on the FDA PCAC peptide decision in July 2026 — committee composition, conflict disclosures, and what it means for compounding.
For research and educational purposes only. Not medical advice. Direct Answer Six of seven peptides were recommended for 503A compounding list inclusion by the FDA's PCAC on July 23–24, 2026. The votes are non-binding. Nothing is legal to compound today that was not legal last week. But the committee that voted for these peptides included eight temporary members appointed just 24 days before the meeting — and voted directly against the recommendation of the FDA's own career scientists. That context is what most coverage missed entirely. This post covers the context that has been almost entirely absent from reporting on the July 2026 PCAC vote. For the vote scorecard and the five-step regulatory roadmap from advisory recommendation to legal compounding access, see our earlier posts: Day 1 results (BPC-157, TB-500, KPV, MOTS-c) , Day 2 results (Semax, Epitalon, Emideltide) , and the complete regulatory roadmap . This post is about the story inside that story. What Happened: The Vote Scoreboard Every Outlet Published If you have been tracking this story here at RUOcodes.com, you already know the basic timeline. Day 1 saw BPC-157 , KPV , and TB-500 each pass 8–6 with one abstention, and MOTS-c pass 7–5. Day 2 saw Semax pass 8–5 and Epitalon pass 7–5, each with one abstention, while emideltide was voted down 6–7. That is the scoreboard. Every outlet in the country has published it. What they have not published is the context that makes those numbers meaningful. The Story Nobody Told: Who Actually Voted Here is the detail that has been almost completely buried in coverage — and that every researcher following this space deserves to know. Key Fact The committee that voted to recommend six of the seven peptides included eight newly appointed temporary voting members added on June 29, 2026 — just 24 days before the meeting. Read that again. Twenty-four days before a landmark vote on compounds that have been the subject of regulatory controversy for years, eight new temporary…
← Back to Blog